| Evidence-based guideline: treatment of tardive syndromes: report of the Guideline Development Subcommittee of the American Academy of Neurology R Bhidayasiri, S Fahn, WJ Weiner, GS Gronseth, KL Sullivan, ... Neurology 81 (5), 463-469, 2013 | 256 | 2013 |
| Successful use of donepezil for the treatment of psychotic symptoms in patients with Parkinson's disease J Bergman, V Lerner Clinical neuropharmacology 25 (2), 107-110, 2002 | 206 | 2002 |
| L-theanine relieves positive, activation, and anxiety symptoms in patients with schizophrenia and schizoaffective disorder: an 8-week, randomized, double-blind, placebo … MS Ritsner, C Miodownik, Y Ratner, T Shleifer, M Mar, L Pintov, V Lerner The Journal of clinical psychiatry 71 (1), 10913, 2010 | 135 | 2010 |
| Vitamin B6 treatment for tardive dyskinesia: a randomized, double-blind, placebo-controlled, crossover study. V Lerner, C Miodownik, A Kaptsan, Y Bersudsky, I Libov, BA Sela, ... Journal of Clinical Psychiatry 68 (11), 1648-1654, 2007 | 123 | 2007 |
| Tardive dyskinesia (syndrome): current concept and modern approaches to its management PP Lerner, C Miodownik, V Lerner Psychiatry and clinical neurosciences 69 (6), 321-334, 2015 | 122 | 2015 |
| Combination of “atypical” antipsychotic medication in the management of treatment-resistant schizophrenia and schizoaffective disorder V Lerner, I Libov, M Kotler, RD Strous Progress in Neuro-Psychopharmacology and Biological Psychiatry 28 (1), 89-98, 2004 | 117 | 2004 |
| Pregnenolone and dehydroepiandrosterone as an adjunctive treatment in schizophrenia and schizoaffective disorder: an 8-week, double-blind, randomized, controlled, 2-center … MS Ritsner, A Gibel, T Shleifer, I Boguslavsky, A Zayed, R Maayan, ... Journal of Clinical Psychiatry 71 (10), 1351, 2010 | 114 | 2010 |
| Vitamin B6 in the treatment of tardive dyskinesia: a double-blind, placebo-controlled, crossover study V Lerner, C Miodownik, A Kaptsan, H Cohen, M Matar, U Loewenthal, ... American Journal of Psychiatry 158 (9), 1511-1514, 2001 | 113 | 2001 |
| Curcumin as an add-on to antidepressive treatment: a randomized, double-blind, placebo-controlled, pilot clinical study J Bergman, C Miodownik, Y Bersudsky, S Sokolik, PP Lerner, A Kreinin, ... Clinical neuropharmacology 36 (3), 73-77, 2013 | 108 | 2013 |
| Vitamin B12 and folate serum levels in newly admitted psychiatric patients V Lerner, M Kanevsky, T Dwolatzky, T Rouach, R Kamin, C Miodownik Clinical Nutrition 25 (1), 60-67, 2006 | 107 | 2006 |
| Combined use of risperidone and olanzapine in the treatment of patients with resistant schizophrenia [colon] a preliminary case series report V Lerner, B Chudakova, S Kravets, I Polyakova Clinical neuropharmacology 23 (5), 284-286, 2000 | 91 | 2000 |
| Efficacy of piracetam in the treatment of tardive dyskinesia in schizophrenic patients: a randomized, double-blind, placebo-controlled crossover study. I Libov, C Miodownik, Y Bersudsky, T Dwolatzky, V Lerner Journal of Clinical Psychiatry 68 (7), 1031-1037, 2007 | 71 | 2007 |
| Vitamin B~ 6 Treatment in Acute Neuroleptic-Induced Akathisia: A Randomized, Double-Blind, Placebo-Controlled Study V Lerner, J Bergman, N Statsenko, C Miodownik Journal of Clinical Psychiatry 65 (11), 1550-1554, 2004 | 69 | 2004 |
| Characteristics of suicidal attempts in major depression versus adjustment reactions I Polyakova, HY Knobler, A Ambrumova, V Lerner Journal of affective disorders 47 (1-3), 159-167, 1998 | 59 | 1998 |
| Donepezil as add-on treatment of psychotic symptoms in patients with dementia of the Alzheimer's type J Bergman, I Brettholz, M Shneidman, V Lerner Clinical neuropharmacology 26 (2), 88-92, 2003 | 58 | 2003 |
| The use of humor with chronic schizophrenic patients E Witztum, S Briskin, V Lerner Journal of Contemporary Psychotherapy 29 (3), 223-234, 1999 | 58 | 1999 |
| Vitamin B6 versus mianserin and placebo in acute neuroleptic-induced akathisia: a randomized, double-blind, controlled study C Miodownik, V Lerner, N Statsenko, T Dwolatzky, B Nemets, E Berzak, ... Clinical neuropharmacology 29 (2), 68-72, 2006 | 57 | 2006 |
| Curcumin as add-on to antipsychotic treatment in patients with chronic schizophrenia: a randomized, double-blind, placebo-controlled study C Miodownik, V Lerner, N Kudkaeva, PP Lerner, A Pashinian, ... Clinical neuropharmacology 42 (4), 117-122, 2019 | 56 | 2019 |
| Serum levels of brain-derived neurotrophic factor and cortisol to sulfate of dehydroepiandrosterone molar ratio associated with clinical response to L-theanine as augmentation … C Miodownik, R Maayan, Y Ratner, V Lerner, L Pintov, M Mar, A Weizman, ... Clinical neuropharmacology 34 (4), 155-160, 2011 | 56 | 2011 |
| The retinoid X receptor agonist bexarotene relieves positive symptoms of schizophrenia: a 6-week, randomized, double-blind, placebo-controlled multicenter trial V Lerner, C Miodownik, A Gibel, P Sirota, I Bush, H Elliot, R Benatov, ... The Journal of clinical psychiatry 74 (12), 18230, 2013 | 54 | 2013 |
